Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses

NCT01914952 is registered in ClinicalTrials.gov with Metabolic Technologies Inc. as lead sponsor.

NCT NCT01914952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01914952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alternate Dosing Strategies for Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation: Effect on Plasma HMB Responses
Lead sponsor
Metabolic Technologies Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2013
Completion date
May 31, 2014
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

focus of the study is to examine plasma hmb levels after oral hmb supplementation